Brett Coldiron, M.D., offers insight on how recent legislative and regulatory changes may impact your practice.
A growing body of evidence supports treating melasma with systemic or intradermal tranexamic acid. But melasma patients often relapse when they stop taking the antifibrinolytic agent, and research on tranexamic acid’s long-term efficacy and safety is limited.
A literature review on clinical evidence for melasma treatments suggests an evidence-based treatment ladder.
In this interview, Dr. Anna De Benedetto discusses what initially drew her to dermatology and what inspired her to study atopic dermatitis in the elderly.
From this year’s Global Aesthetic Conference, Dr. Dev Patel discusses using plasma energy for skin tightening and more.
Adults 60 and older tend to have a distinct atopic dermatitis presentation and important comorbidities, but dermatologists treating these patients find lacking evidence on how to diagnose and best treat atopic dermatitis in the elderly, according to a recent review.
The treatment of hair loss requires the use of combination therapies, along with mandatory maintenance.
Dermatology Times talked with several experts over the course of the Fall Clinical Dermatology meeting to glean practical insights from their presentations.
Malignant melanoma can mimic many melanocytic lesions and vice versa, making it a difficult diagnosis. As such, accurate diagnosis should be a collaborative effort between clinician and dermatopathologist, says this expert.
Psoriasis often has a greater impact on quality of life in patients with skin of color as the condition and its treatment can result in long-lasting pigmentary changes.